Company Profile

Ascendis Pharma A/S (NASDAQ: ASND)
4:45 PM UTC, 05/23/24
Last: $131.31 Change: +0.17 %Change: +0.13% Volume: 145,617
Detailed Quote
Open: $ 131.45   Volume: 145,617
High: $ 132.26   Yield(%) 0.00
Low: $ 127.78   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 7.42B
EPS ($) -9.64   Shares Out: 56.61M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -8.41
% Price Change (last 13 weeks): -16.55
% Price Change (last 26 weeks): 41.01
% Price Change (last 52 weeks): 47.66
% Price Change (year to date): 4.12
Management Effectiveness
Return on Equity (%): -866.68
Return on Assets (%): -50.17
Return on Invested Capital (%): -56.61
Profitability
Gross Profit Margin (%): 78.07
Net Profit Margin (%): -180.51
Operating Profit Margin (%): -170.79
Price & Volume
50-day Moving Average: $141.07
200-day Moving Average: $119.65
Avg. Daily Vol. (last 50 days): 384,984
Avg. Daily Vol. (last 200 days): 434,748
52-wk high: $161.00
52-wk low: $83.75
Bid: $131.18
Ask: $131.44
Company Information
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Ascendis Pharma A/S
Tuborg Boulevard 12
Hellerup CR 2900

Phone: 45.70.22.22.44
Fax: n/a
http://www.ascendispharma.com
Per Share Data
Earnings (1year) ($): -9.64
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): -2.84
Cash Flow ($): -8.83
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 24.59
Price/Book (x): n/a
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 2.50
Current Ratio (x): 3.56
LT Debt/Equity (x): n/a
Total Debt/Equity (x): n/a



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.